Sale!

FGFR1 Gene Kallmann Syndrome Type 2 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The FGFR1 Gene Kallmann Syndrome Type 2 Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, aimed at identifying mutations in the FGFR1 gene, which are associated with Kallmann Syndrome Type 2. Kallmann Syndrome is a genetic condition characterized by the combination of delayed or absent puberty and an impaired sense of smell (anosmia). The FGFR1 gene plays a critical role in the development of the olfactory system and certain hormonal axes responsible for sexual development. Mutations in this gene can disrupt these processes, leading to the symptoms observed in Kallmann Syndrome.

The test is priced at 4400 AED and involves collecting a DNA sample from the patient, typically through a blood draw or a cheek swab. The sample is then analyzed in the laboratory to detect any genetic variations in the FGFR1 gene that are known to contribute to the condition. This genetic testing is crucial for the accurate diagnosis of Kallmann Syndrome Type 2, enabling healthcare providers to offer appropriate treatment and counseling for affected individuals and their families. DNA Labs UAE employs state-of-the-art genetic testing technologies to ensure high accuracy and reliability of the test results.

Description

FGFR1 Gene Kallmann Syndrome Type 2 Genetic Test

Test Name: FGFR1 Gene Kallmann syndrome type 2 Genetic Test

Components: DNA Labs UAE

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Dysmorphology

Doctor: Pediatrics

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for FGFR1 Gene Kallmann syndrome type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with FGFR1 Gene Kallmann syndrome type 2 NGS Genetic DNA Test gene FGFR1

Test Details: The FGFR1 gene is associated with Kallmann syndrome type 2, which is a genetic disorder characterized by delayed or absent puberty and a reduced sense of smell (anosmia). Kallmann syndrome is caused by mutations in genes involved in the development and migration of nerve cells that control the production of hormones necessary for sexual development. NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that allows for the simultaneous analysis of multiple genes or even the entire genome. It uses advanced sequencing technologies to rapidly and accurately sequence large amounts of DNA. In the case of Kallmann syndrome type 2, NGS genetic testing can be used to identify mutations in the FGFR1 gene or other genes associated with the disorder. NGS genetic testing for Kallmann syndrome type 2 involves obtaining a DNA sample, typically through a blood or saliva sample, and sequencing the relevant genes. The sequencing data is then analyzed to identify any mutations or variants that may be causing the disorder. This information can help with diagnosis, genetic counseling, and potentially guide treatment options. It is important to note that NGS genetic testing for Kallmann syndrome type 2 should be performed by a qualified healthcare professional or genetic counselor who can interpret the results and provide appropriate guidance and support.

Test Name	FGFR1 Gene Kallmann syndrome type 2 Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Dysmorphology
Doctor	Pediatrics
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for FGFR1 Gene Kallmann syndrome type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with FGFR1 Gene Kallmann syndrome type 2 NGS Genetic DNA Test gene FGFR1
Test Details	The FGFR1 gene is associated with Kallmann syndrome type 2, which is a genetic disorder characterized by delayed or absent puberty and a reduced sense of smell (anosmia). Kallmann syndrome is caused by mutations in genes involved in the development and migration of nerve cells that control the production of hormones necessary for sexual development. NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that allows for the simultaneous analysis of multiple genes or even the entire genome. It uses advanced sequencing technologies to rapidly and accurately sequence large amounts of DNA. In the case of Kallmann syndrome type 2, NGS genetic testing can be used to identify mutations in the FGFR1 gene or other genes associated with the disorder. NGS genetic testing for Kallmann syndrome type 2 involves obtaining a DNA sample, typically through a blood or saliva sample, and sequencing the relevant genes. The sequencing data is then analyzed to identify any mutations or variants that may be causing the disorder. This information can help with diagnosis, genetic counseling, and potentially guide treatment options. It is important to note that NGS genetic testing for Kallmann syndrome type 2 should be performed by a qualified healthcare professional or genetic counselor who can interpret the results and provide appropriate guidance and support.